ArticleClinical cancer research : an official journal of the American Association for Cancer Research2026
The Pharmacologic Profile of ART6043, a First-in-Class Clinical DNA Polymerase Theta Polymerase Domain Inhibitor Potentiating PARP Inhibitor Efficacy.
Helen M R Robinson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.